2024

• Haque, M., Tannous, W., Herman, W., Immanuel, J., Hague, W., Teede, H., Enticott, J., Cheung, N., Hibbert, E., Nolan, C., et al (2024). Cost-effectiveness of diagnosis and treatment of early gestational diabetes mellitus: economic evaluation of the TOBOGM study, an international multicenter randomized controlled trial. EClinicalMedicine, 71. [More Information]
• Simmons, D., Wong, V., Hibbert, E., Kautzky-Willer, A., Harreiter, J., Backman, H., Gianatti, E., Sweeting, A., Mohan, V., Cheung, N., et al (2024). Effect of treatment for early gestational diabetes mellitus on neonatal respiratory distress: A secondary analysis of the TOBOGM study. BJOG. [More Information]
• Sweeting, A., Hannah, W., Backman, H., Catalano, P., Feghali, M., Herman, W., Hivert, M., Immanuel, J., Meek, C., Oppermann, M., et al (2024). Epidemiology and management of gestational diabetes. The Lancet, 404(10448), 175-192. [More Information]
• Hivert, M., Backman, H., Benhalima, K., Catalano, P., Desoye, G., Immanuel, J., McKinlay, C., Meek, C., Nolan, C., Ram, U., Sweeting, A., et al (2024). Pathophysiology from preconception, during pregnancy, and beyond. The Lancet, 404(10448), 158-174. [More Information]
• Sweeting, A., Enticott, J., Immanuel, J., Hague, W., Teede, H., Nolan, C., Peek, M., Flack, J., Hibbert, E., Cheung, N., et al (2024). Relationship Between Early-Pregnancy Glycemia and Adverse Outcomes: Findings From the TOBOGM Study. Diabetes Care, 47(12), 2085-2092. [More Information]
• Lee, V., Houston, L., Perkovic, A., Barraclough, J., Sweeting, A., Yu, J., Fletcher, R., Arnott, C. (2024). The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction—A Systematic Review and Meta-Analysis of Randomised Controlled Trials. Heart, Lung, and Circulation. [More Information]
• Sweeting, A., MacMillan, F., Simmons, D. (2024). The first International Association of Diabetes and Pregnancy Study Groups summit on the diagnosis of gestational diabetes in early pregnancy: TOBOGM Summit Report. Australian and New Zealand Journal of Obstetrics and Gynaecology. [More Information]

2023

• Simmons, D., Sweeting, A. (2023). Defining gestational diabetes: not just about cutoffs. The Lancet Diabetes & Endocrinology, 11(5), P303-P304. [More Information]
• Jamieson, E., Dimeski, G., Flatman, R., Hickman, P., Jones, G., Marley, J., McIntyre, D., McNeil, A., Sweeting, A., Williams, P., et al (2023). Oral glucose tolerance test to diagnose gestational diabetes mellitus: Impact of variations in specimen handling. Clinical Biochemistry, 115, 33-48. [More Information]
• Francis, E., Powe, C., Lowe, W., White, S., Scholtens, D., Yang, J., Zhu, Y., Zhang, C., Hivert, M., Kwak, S., Sweeting, A. (2023). Refining the diagnosis of gestational diabetes mellitus: a systematic review and meta-analysis. Communications Medicine, 3(1), 185. [More Information]
• Tobias, D., Merino, J., Ahmad, A., Aiken, C., Benham, J., Bodhini, D., Clark, A., Colclough, K., Corcoy, R., Cromer, S., Sweeting, A., et al (2023). Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. Nature Medicine, 29(10), 2438-2457. [More Information]
• Yu, J., Berwanger, O., Heerspink, H., de Zeeuw, D., Arnott, C., Sweeting, A., Gianacas, C., Houston, L., Lee, V., Fletcher, R., et al (2023). The effects of canagliflozin in type 2 diabetes in subgroups defined by population-specific body mass index: Insights from the CANVAS Program and CREDENCE trial. Diabetes, Obesity and Metabolism, 25(12), 3724-3735. [More Information]
• Reyes, P., Immanuel, J., Hague, W., Teede, H., Hibbert, E., Nolan, C., Peek, M., Wong, V., Flack, J., Mclean, M., Cheung, N., et al (2023). The relationship between body mass index and sleep in women with risk factors for gestational diabetes mellitus. Obesity Science & Practice, 9(6), 573-580. [More Information]
• Simmons, D., Immanuel, J., Hague, W., Teede, H., Nolan, C., Peek, M., Flack, J., McLean, M., Wong, V., Sweeting, A., et al (2023). Treatment of Gestational Diabetes Mellitus Diagnosed Early in Pregnancy. New England Journal of Medicine, 388(23), 2132-2144. [More Information]
• Kim, M., Holton, M., Sweeting, A., Koreshe, E., McGeechan, K., Miskovic-Wheatley, J. (2023). Using health administrative data to model associations and predict hospital admissions and length of stay for people with eating disorders. BMC Psychiatry, 23(1), 326. [More Information]

2022

• Sweeting, A., Wong, J., Murphy, H., Ross, G. (2022). A Clinical Update on Gestational Diabetes Mellitus. Endocrine Reviews, 43(5), 763-793. [More Information]
• Caterson, I., Sweeting, A., Kopelman, P. (2022). A Practical Approach to Contemporary Obesity Management. Clinical Obesity in Adults and Children (4th Edition), (pp. 223-231). United Kingdom: John Wiley & Sons. [More Information]
• Kopelman, P., Caterson, I., Dietz, W., Armstrong, S., Sweeting, A., Wilding, J. (2022). Clinical Obesity in Adults and Children, 4th Edition. TBC. [More Information]
• Sweeting, A., Hsieh, A., Wong, J., Ross, G. (2022). Comparison of a subcutaneous versus intravenous insulin protocol for managing hyperglycemia following antenatal betamethasone in women with diabetes: a pilot randomized controlled trial. The Journal of Maternal-Fetal and Neonatal Medicine. [More Information]
• McIntyre, H., Sweeting, A. (2022). Gestational diabetes in Australia: navigating a tsunami. The Lancet Diabetes and Endocrinology, 10(12), 846-847. [More Information]
• Ferris, L., De Vries, B., Sweeting, A. (2022). Management of obesity in pregnancy. Australian and New Zealand Journal of Obstetrics and Gynaecology, 62(5), 623-625. [More Information]
• Seimon, R., Natasha, N., Schneuer, F., Pereira, G., Mackie, A., Ross, G., Sweeting, A., Seeho, S., Hocking, S. (2022). Maternal and neonatal outcomes of women with gestational diabetes and without specific medical conditions: an Australian population-based study comparing induction of labor with expectant management. Australian and New Zealand Journal of Obstetrics and Gynaecology, 62(4), 525-535. [More Information]
• Sweeting, A. (2022). Obesity and Fertility. Clinical Obesity in Adults and Children (4th Edition), (pp. 154-158). United Kingdom: John Wiley & Sons. [More Information]

2021

• Muirhead, R., Kizirian, N., Lal, R., Black, K., Prys-Davies, A., Nassar, N., Baur, L., Sainsbury, A., Sweeting, A., Markovic, T., Skilton, M., Hyett, J., De Vries, B., Tarnow-Mordi, W., Brand-Miller, J., Gordon, A. (2021). A Pilot Randomized Controlled Trial of a Partial Meal Replacement Preconception Weight Loss Program for Women with Overweight and Obesity. Nutrients, 13(9), 3200. [More Information]
• Immanuel, J., Flack, J., Wong, V., Yuen, L., Eagleton, C., Graham, D., Lagstrom, J., Wolmarans, L., Martin, M., Cheung, N., et al (2021). The adips pilot national diabetes in pregnancy benchmarking programme. International Journal of Environmental Research and Public Health, 18(9), 4899. [More Information]
• Sweeting, A., Mijatovic, J., Brinkworth, G., Markovic, T., Ross, G., Brand-Miller, J., Hernandez, T. (2021). The Carbohydrate Threshold in Pregnancy and Gestational Diabetes: How Low Can We Go? Nutrients, 13(8), 2599. [More Information]

2020

• Franklin, J., Sweeting, A., Gibson, A., Caterson, I. (2020). Adjunctive therapies for obesity: Pharmacotherapy, VLEDs and bariatric surgery. Medicine Today, 21(10), 21-29.
• Sweeting, A., Ross, G. (2020). An update on gestational diabetes mellitus. Medicine Today, 21(11), 33-42.

2019

• Sweeting, A., Wong, J., Appelblom, H., Ross, G., Kouru, H., Williams, P., Sairanen, M., Hyett, J. (2019). A Novel Early Pregnancy Risk Prediction Model for Gestational Diabetes Mellitus. Fetal Diagnosis and Therapy, 45(2), 76-84. [More Information]
• Sweeting, A., Chua, E. (2019). Management of Endocrine Disorders and the Pharmacist's Role: Adrenal Insufficiency. In Not known (Eds.), Encyclopedia of Pharmacy Practice and Clinical Pharmacy, (pp. 437-446). TBC. [More Information]

2018

• Sweeting, A., Wong, J., Appelblom, H., Ross, G., Kouru, H., Williams, P., Sairanen, M., Hyett, J. (2018). A first trimester prediction model for gestational diabetes utilizing aneuploidy and pre-eclampsia screening markers. The Journal of Maternal-Fetal and Neonatal Medicine, 31(16), 2122-2130. [More Information]
• Gray, S., Sweeting, A., McGuire, T., Cohen, N., Ross, G., Little, P. (2018). Changing environment of hyperglycemia in pregnancy: Gestational diabetes and diabetes mellitus in pregnancy. Journal of Diabetes, 10(8), 633-640. [More Information]
• Lomax, A., Lim, J., Cheng, R., Sweeting, A., Lowe, P., McGill, N., Shackel, N., Chua, E., McNeil, C. (2018). Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management. Journal of Skin Cancer, 2018, 9602540. [More Information]
• Hsu, M., Harper, C., Gibson, A., Sweeting, A., McBride, J., Markovic, T., Caterson, I., Byrne, N., Salis (nee Sainsbury), A., Seimon, R. (2018). Recruitment Strategies for a Randomised Controlled Trial Comparing Fast Versus Slow Weight Loss in Postmenopausal Women with Obesity-The TEMPO Diet Trial. Healthcare, 6(3), 1-17. [More Information]

2017

• Sweeting, A., Caterson, I. (2017). Approaches to obesity management. Internal Medicine Journal, 47(7), 734-739. [More Information]
• Sweeting, A., Ross, G., Hyett, J., Molyneaux, L., Tan, K., Constantino, M., Harding, A., Wong, J. (2017). Baseline HbA1c to identify high-risk gestational diabetes: Utility in early vs standard gestational diabetes. The Journal of Clinical Endocrinology and Metabolism, 102(1), 150-156. [More Information]
• Sweeting, A., Caterson, I. (2017). Control of Weight: How Do We Get Fat? In RICHARD I.G. HOLT, CLIVE S. COCKRAM, ALLAN FLYVBJERG, BARRY J. GOLDSTEIN (Eds.), Textbook of Diabetes, (pp. 133-139). United Kingdom: Wiley Blackwell. [More Information]
• Sweeting, A., Appelblom, H., Ross, G., Wong, J., Kouru, H., Williams, P., Sairanen, M., Hyett, J. (2017). First trimester prediction of gestational diabetes mellitus: A clinical model based on maternal demographic parameters. Diabetes Research and Clinical Practice, 127, 44-50. [More Information]
• Sweeting, A., Ross, G., Hyett, J., Wong, J. (2017). Gestational diabetes in the first trimester: is early testing justified? The Lancet Diabetes and Endocrinology, 5(8), 571-573. [More Information]
• Maggioni, A., Caterson, I., Urso, R., Coutinho, W., Finer, N., Van Gaal, L., Legler, U., Sharma, A., Seimon, R., Sweeting, A., et al (2017). Relation between weight loss and causes of death in patients with cardiovascular disease: Finding from the SCOUT trial. Journal of Cardiovascular Medicine (Hagerstown), 18(3), 144-151. [More Information]

2016

• Sweeting, A., Ross, G., Hyett, J., Molyneaux, L., Constantino, M., Harding, A., Wong, J. (2016). Gestational Diabetes Mellitus in Early Pregnancy: Evidence for Poor Pregnancy Outcomes Despite Treatment. Diabetes Care, 39(1), 75-81. [More Information]
• Sweeting, A., Caterson, I. (2016). Liraglutide: For obesity, not just type 2 diabetes. Medicine Today, 17(5), 69-71.

2015

• Seimon, R., Espinoza, D., Finer, N., James, W., Legler, U., Coutinho, W., Sharma, A., Van Gaal, L., Maggioni, A., Sweeting, A., Gebski, V., Caterson, I., et al (2015). Changes in body weight and pulse: outcome events in overweight and obese subjects with cardiovascular disease in the SCOUT trial. International Journal of Obesity, 39(5), 849-857. [More Information]
• Lam, T., Chan, M., Sweeting, A., De Sousa, S., Clements, A., Carlino, M., Long, G., Tonks, K., Chua, E., Kefford, R., Chipps, D. (2015). Ipilimumab-induced hypophysitis in melanoma patients: An Australian case series. Internal Medicine Journal, 45(10), 1066-1073. [More Information]
• Sweeting, A., Hocking, S., Markovic, T. (2015). Pharmacotherapy for the Treatment of Obesity. Molecular And Cellular Endocrinology, 418(pt 2), 173-183. [More Information]
• Sweeting, A., Park, F., Hyett, J. (2015). The first trimester: Prediction and prevention of the great obstetrical syndromes. Best Practice and Research: Clinical Obstetrics and Gynaecology, 29(2), 183-193. [More Information]

2014

• Sweeting, A., Tabet, E., Caterson, I., Markovic, T. (2014). Management of obesity and cardiometabolic risk - role of phentermine/extended release topiramate. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, 7, 35-44. [More Information]

2013

• Sweeting, A., Rudland (nee Carleton), V., Ross, G. (2013). Gestational diabetes: Towards new diagnostic criteria. Medicine Today, 14(5), 46-53.